|Bid||133.44 x 200|
|Ask||133.47 x 500|
|Day's Range||132.19 - 133.65|
|52 Week Range||109.32 - 137.08|
|PE Ratio (TTM)||22.37|
|Dividend & Yield||3.36 (2.53%)|
|1y Target Est||N/A|
A jury awarded a woman with ovarian cancer $417 million Monday in a case against Johnson & Johnson, the latest hit to the pharmaceutical company in widespread litigation over the alleged harms of its baby ...
Johnson & Johnson, the world's largest healthcare company, has hit out at plans by the US state of Florida to execute a prisoner on death row using an experimental lethal injection containing a drug it ...
Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of talc-based products.